Cargando…

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction

BACKGROUND: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Nancy, O'Connor, Christopher M., Chiswell, Karen, Anstrom, Kevin J., Newby, L. Kristin, Mentz, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640574/
https://www.ncbi.nlm.nih.gov/pubmed/34901801
http://dx.doi.org/10.1016/j.cjco.2021.06.007
_version_ 1784609359877111808
author Luo, Nancy
O'Connor, Christopher M.
Chiswell, Karen
Anstrom, Kevin J.
Newby, L. Kristin
Mentz, Robert J.
author_facet Luo, Nancy
O'Connor, Christopher M.
Chiswell, Karen
Anstrom, Kevin J.
Newby, L. Kristin
Mentz, Robert J.
author_sort Luo, Nancy
collection PubMed
description BACKGROUND: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well characterized for HF without CHD. We investigated the characteristics and 5-year mortality outcomes among patients with HF without significant CHD, stratified by EF. METHODS: Patients with clinical heart failure who underwent coronary angiography at Duke University Medical Center from 1996 through 2009 and had no significant CHD with EF ≤ 40% were compared with patients without significant CHD with EF > 40%. Survival was examined using Kaplan-Meier methods and multivariable Cox proportional hazards modeling. Analyses were repeated using EF ≥ 50%. RESULTS: Of 3154 patients with HF without significant CHD, 1530 (48.5%) had HFpEF (EF > 40%). These patients were older and more likely to have a Charlson Index ≥ 2 than patients with reduced EF. Patients with HFpEF had a lower risk of death than those with reduced EF (unadjusted hazard ratio [HR] 0.85; 95% confidence interval [CI] 0.74-0.99). From 1996 through 2009, the secular trend of death decreased among patients without CHD and with reduced EF (HR 0.92; 95% CI 0.88-0.97) but not among those with preserved EF (HR 0.99; 95% CI 0.93-1.05; P interaction 0.095). No finding was significant after multivariable risk adjustment. Results were consistent when defining preserved EF as EF ≥ 50%. CONCLUSIONS: Among patients without significant CHD, those with HFpEF had similar risks of 5-year mortality as patients with HF with reduced ejection fraction.
format Online
Article
Text
id pubmed-8640574
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86405742021-12-09 Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction Luo, Nancy O'Connor, Christopher M. Chiswell, Karen Anstrom, Kevin J. Newby, L. Kristin Mentz, Robert J. CJC Open Original Article BACKGROUND: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well characterized for HF without CHD. We investigated the characteristics and 5-year mortality outcomes among patients with HF without significant CHD, stratified by EF. METHODS: Patients with clinical heart failure who underwent coronary angiography at Duke University Medical Center from 1996 through 2009 and had no significant CHD with EF ≤ 40% were compared with patients without significant CHD with EF > 40%. Survival was examined using Kaplan-Meier methods and multivariable Cox proportional hazards modeling. Analyses were repeated using EF ≥ 50%. RESULTS: Of 3154 patients with HF without significant CHD, 1530 (48.5%) had HFpEF (EF > 40%). These patients were older and more likely to have a Charlson Index ≥ 2 than patients with reduced EF. Patients with HFpEF had a lower risk of death than those with reduced EF (unadjusted hazard ratio [HR] 0.85; 95% confidence interval [CI] 0.74-0.99). From 1996 through 2009, the secular trend of death decreased among patients without CHD and with reduced EF (HR 0.92; 95% CI 0.88-0.97) but not among those with preserved EF (HR 0.99; 95% CI 0.93-1.05; P interaction 0.095). No finding was significant after multivariable risk adjustment. Results were consistent when defining preserved EF as EF ≥ 50%. CONCLUSIONS: Among patients without significant CHD, those with HFpEF had similar risks of 5-year mortality as patients with HF with reduced ejection fraction. Elsevier 2021-06-17 /pmc/articles/PMC8640574/ /pubmed/34901801 http://dx.doi.org/10.1016/j.cjco.2021.06.007 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Luo, Nancy
O'Connor, Christopher M.
Chiswell, Karen
Anstrom, Kevin J.
Newby, L. Kristin
Mentz, Robert J.
Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
title Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
title_full Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
title_fullStr Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
title_full_unstemmed Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
title_short Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
title_sort survival in patients with nonischemic cardiomyopathy with preserved vs reduced ejection fraction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640574/
https://www.ncbi.nlm.nih.gov/pubmed/34901801
http://dx.doi.org/10.1016/j.cjco.2021.06.007
work_keys_str_mv AT luonancy survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction
AT oconnorchristopherm survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction
AT chiswellkaren survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction
AT anstromkevinj survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction
AT newbylkristin survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction
AT mentzrobertj survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction